-transparent.png){kind=logo}
Cis-Diamminedichloroplatinum (CDDP)-lipiodol suspension (CLS) was developed as a transarterial chemoembolization (TACE) material. The CLS was injected into the proper hepatic artery or distal branches of patients with hepatocellular carcinoma. Strong anticancer effects were observed. Plasma concentrations of total and filtrable CDDP following TACE were much lower than those following intravenous administration of CDDP solution. No major adverse complications were noted, presumably due to low CDDP concentrations in circulating plasma. The CLS appears to be an excellent TACE material.
Related Publications
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
June 2017,
Anticancer research,
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
June 2014,
Critical care medicine,
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
February 2024,
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
January 2012,
Hepato-gastroenterology,
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
October 2016,
Neurological research,
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
September 2011,
Anticancer research,
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
January 1992,
Radiation medicine,
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
January 2000,
Cardiovascular and interventional radiology,
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
July 1988,
Nihon Gan Chiryo Gakkai shi,
T Araki, and
T Hihara, and
K Kachi, and
M Matsusako, and
M Ito, and
K Kohno, and
G Uchiyama
August 1988,
Gan to kagaku ryoho. Cancer & chemotherapy,
